Cas No.: | 1446770-54-2 |
Chemical Name: | (R)-N-(2-((1-(3-(trifluoromethyl)phenyl)ethyl)amino)-1H-benzo[d]imidazol-4-yl)acetamide |
Synonyms: | AP-14145;AP 14145 |
SMILES: | C(NC1=C2N=C(N[C@H](C3=CC=CC(C(F)(F)F)=C3)C)NC2=CC=C1)(=O)C |
Formula: | C18H17F3N4O |
M.Wt: | 362.356 |
Purity: | >98% |
Sotrage: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
Description: | AP14145 (AP-14145) is a potent, selective negative allosteric modulator of KCa2.2 and KCa2.3 with equal potency (IC50=1.1±0.3 uM); displays weak inhibition against hKCa1.1 and hKCa3.1 channels using whole cell patch clamp test (IC50~10 uM), does not affect hKCa3.1 currents; reverses the effect of the positive KCa2 gating modulator NS309, increases the EC50 of Ca2+ on KCa 2.3 channels from 0.36 to 1.2 uM at 10 uM; The inhibitory effect strongly depended on two amino acids, S508 and A533 in the channel; AP14145 concentration-dependently prolongs atrial effective refractory period (AERP) in rats, does not trigger any apparent CNS effects in mice. |